Adjust your drug plan strategy to manage specialty medication costs
By Chris Hanson-EhlingerWed, Mar, 05, 2014
Brian Bullock, Founder and CEO at The Burchfield Group, presented his perspectives on prescription drug innovation at the Minnesota Health Action Group’s 7th Annual Leadership Summit, Moving Forward in Uncertain Times, on February 21.
Chris Hanson-EhlingerWed, Mar, 05, 2014
- How PBMs Make Money in the Medicare Part D Market – A GAO Report Analysis
- CMS Issues New Proposed Protocols for Medicare Part C and D Program Audits and Part C Timeliness Monitoring Project. Proposed Changes Would Take Effect in 2021 Audit Year.
- PBM Impact from COVID-19
- Zolgensma: Nine Steps Health Plans Can Take to Reduce Financial Exposure
- What Health Plans Need to Know about Medicaid Encounter Data